ArticleBlood cancer discovery2025

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

David Fandrei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.